Congruence Therapeutics

0 followers

‌

Congruence Therapeutics operates as a biotechnology company working at the interface of computational and experimental drug discovery to design novel small molecules for diseases of protein misfolding.

Industries

Headquarters

Employees

Links

Org chart

Katherine Bonter

Executive Director IP and Founder

Katherine Bonter

Collapse

Charles Grubsztajn

Chief Operating Officer

Michael-Rock Goldsmith, Ph.D.

Co-founder & Chief Innovation Scientist

Priya Karnick

Finance Manager

Sharath Hegde

Chief Scientific Officer

Teams

Scientific Research Team

10 members

Leadership Team

7 members

Chemistry and Biology Team

5 members

Similar companies

Forge Biologics

2 followers

Merck

201 followers

Réseau de Santé Vitalité

1 follower

Caribou Biosciences

1 follower

Ontario Medical Association

1 follower

BioAge

3 followers

Biron Health Group | Biron Groupe Santé

1 follower

Mineralys Therapeutics

1 follower

Confo Therapeutics

1 follower

Dentira

1 follower

Elektrofi

1 follower

Discover companies